Lanean...
Recent advances in managing axial spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that predominantly affects the axial skeleton. The advent of biologic drugs has transformed the management of patients with axSpA. However, non-steroidal anti-inflammatory drugs remain the first-line drug treatment for axSpA...
Gorde:
| Argitaratua izan da: | F1000Res |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
F1000 Research Limited
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359748/ https://ncbi.nlm.nih.gov/pubmed/32704350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.22577.1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|